Departed
Amir Vasquez
Chief Financial Officer
AWCA ·
Awaysis Capital, Inc.
accepted the resignation of Amir Vasquez, the Company’s then-Chief Financial Officer.
Executive movement radar
Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 8001–8050 of 18431
Departed
Andrew D. Sklawer
President and Chief Executive Officer
Fresh Tracks Therapeutics, Inc.
the Company terminated Andrew D. Sklawer, the Company’s President and Chief Executive Officer, without cause, effective October 2, 2023
Role change
Thane Wettig
Chief Executive Officer
KYNB ·
KYNTRA BIO, INC.
On October 2, 2023, the Board of Directors (the “Board”) of FibroGen, Inc. (the “Company”) appointed Interim Chief Executive Officer Thane Wettig as (i) Chief Executive Officer and (ii) a member of the Board.
Role change
James G. Petcoff
Executive Chairman and Co-Chief Executive Officer
PRHI ·
Presurance Holdings, Inc.
Consequently, James G. Petcoff will be stepping down as Executive Chairman and Co-Chief Executive Officer, effective December 31, 2023.
Role change
Nicholas J. Petcoff
Chief Executive Officer
PRHI ·
Presurance Holdings, Inc.
Effective December 31, 2023, Nicholas J. Petcoff will become sole Chief Executive Officer of Conifer Holdings, Inc.
Appointed
(interim)
Craig K. Clement
interim Chief Executive Officer
DTGI ·
Digerati Technologies, Inc.
On October 6, 2023, the Board of Directors of the Company (the “Board”) appointed Craig K. Clement, the current Executive Chairman of the Company, as interim CEO during Mr. Smith’s temporary medical leave of absence.
Departed
Arthur L. Smith
Chief Executive Officer
DTGI ·
Digerati Technologies, Inc.
On October 6, 2023, Arthur L. Smith, the Chief Executive Officer (“CEO”) of Digerati Technologies, Inc. (the “Company”), notified the Company that he will take a temporary medical leave of absence from his role as CEO, effective immediately, in connection with his recent surgery.
Role change
Raynauld Liang
Chief Executive Officer
SOPA ·
SOCIETY PASS INCORPORATED.
On October 5, 2023, Raynauld Liang was appointed as the new Chief Executive Officer of the Company.
Departed
Dennis Nguyen
Director, Chairman and Chief Executive Officer
SOPA ·
SOCIETY PASS INCORPORATED.
Mr. Liang’s appointment was concurrent with the resignation of Dennis Nguyen, on October 5, 2023, as a director of the Company, and as the Chairman and the Chief Executive Officer of the Company
Appointed
Yee Siong Tan
Chief Financial Officer
SOPA ·
SOCIETY PASS INCORPORATED.
In conjunction with Mr. Liang’s resignation, Yee Siong Tan was appointed as the Chief Financial Officer of the Company.
Appointed
Joseph Mullin
Chief Executive Officer and President
RYES ·
Rise Gold Corp.
pursuant to which the Company has engaged the Consultant to provide consulting services to the Company, including providing the services of Mr. Mullin on a 50% time commitment basis as the Company's Chief Executive Officer and President
Role change
Matthew Franklin
President and Chief Executive Officer
Akili, Inc.
the appointment of Matthew Franklin, the Company’s President and Chief Operating Officer, to President and Chief Executive Officer and principal executive officer of the Company, effective as of the Transition Date.
Appointed
(interim)
Natalie McAndrew
Interim Chief Financial Officer
Baudax Bio, Inc.
On October 5, 2023, the board of directors of the Company appointed Natalie McAndrew as Interim Chief Financial Officer, effective as of the Effective Date.
Departed
Teresa Luong
Chief Financial Officer
TrueCar, Inc.
the Company had terminated the employment of Teresa Luong as Chief Financial Officer of the Company effective October 2, 2023.
Departed
Greg Weaver
Executive Vice President and Chief Financial Officer
ATOS ·
ATOSSA THERAPEUTICS, INC.
Mr. Weaver tendered his resignation to pursue other opportunities and not due to any disagreement with the Company.
Appointed
Heather Rees
principal financial and accounting officer
ATOS ·
ATOSSA THERAPEUTICS, INC.
In connection with Mr. Weaver’s resignation, the Company has appointed Heather Rees, age 51, as the Company’s principal financial and accounting officer.
Appointed
(interim)
Scott Cox
Interim Chief Executive Officer
THC Therapeutics, Inc.
Scott Cox was appointed as Interim CEO of the Company
Departed
Brandon Romanek
Chief Executive Officer
THC Therapeutics, Inc.
On September 29, 2023, Brandon Romanek resigned as CEO of THC Therapeutics, Inc.
Departed
Simon Allen
Chief Executive Officer
ANEB ·
Anebulo Pharmaceuticals, Inc.
On October 6, 2023, Anebulo Pharmaceuticals, Inc., a Delaware corporation (the “Company”), terminated without cause the employment of Simon Allen, the Company’s Chief Executive Officer.
Appointed
Richard (Richie) Anthony Cunningham
Chief Executive Officer
ANEB ·
Anebulo Pharmaceuticals, Inc.
the Board appointed Richard (Richie) Anthony Cunningham as the Company’s Chief Executive Officer and as a member of the Board.
Appointed
Craig Shore
Chief Financial Officer, Secretary and Treasurer
NSPR ·
InspireMD, Inc.
On October 5, 2023, Mr. Shore was reappointed as the Chief Financial Officer, Secretary and Treasurer of the Company.
Appointed
Gurvinder Singh
Chief Executive Officer
Bright Green Corp
Gurvinder Singh was appointed Chief Executive Officer of the Company, effective as of October 2, 2023.
Departed
Seamus McAuley
Chief Executive Officer
Bright Green Corp
Effective as of October 2, 2023, Seamus McAuley, the Chief Executive Officer of Bright Green Corporation, a Delaware corporation (the “Company”), resigned from his position as Chief Executive Officer of the Company in connection with the appointment of Gurvinder Singh as Chief Executive Officer, as described below.
Departed
Michael C. Pearl
Vice President, Chief Financial Officer and Treasurer
USAC ·
USA Compression Partners, LP
On October 5, 2023, Michael C. Pearl, Vice President, Chief Financial Officer and Treasurer of USA Compression GP, LLC (the “ Company ”), the general partner of USA Compression Partners, LP (the “ Partnership ”), submitted his resignation to pursue other opportunities.
Appointed
G. Tracy Owens
principal financial officer
USAC ·
USA Compression Partners, LP
On October 5, 2023, the board of directors of the Company designated G. Tracy Owens to serve as the principal financial officer of the Company, to be effective October 6, 2023.
Appointed
George N. Mattson
Chief Executive Officer
UP ·
Wheels Up Experience Inc.
on October 2, 2023, Mr. Mattson joined the Company as Chief Executive Officer
Appointed
Sandra L. Rivera
Chief Executive Officer of Programmable Solutions Group
INTC ·
INTEL CORP
On October 3, 2023, Intel Corporation (“Intel”) announced that Sandra L. Rivera will assume the role of Chief Executive Officer of Programmable Solutions Group (“PSG”), an Intel standalone business, and the effective date of this transition (“Effective Date”) is anticipated to occur on January 1, 2024.
Departed
Anil Mathews
Chief Executive Officer
Near Intelligence, Inc.
On October 1, 2023, the Board placed Anil Mathews, the Company’s Chief Executive Officer, Rahul Agarwal, the Company’s Chief Financial Officer, and Shobhit Shukla, the Company’s President, on administrative leave from their respective positions with the Company pending an internal investigation conducted by outside legal counsel on behalf of the Committee.
Appointed
(interim)
John Faieta
interim Chief Financial Officer
Near Intelligence, Inc.
On October 1, 2023, the Board appointed John Faieta, the Company’s Controller, to serve as the Company’s interim Chief Financial Officer.
Departed
Rahul Agarwal
Chief Financial Officer
Near Intelligence, Inc.
On October 1, 2023, the Board placed Anil Mathews, the Company’s Chief Executive Officer, Rahul Agarwal, the Company’s Chief Financial Officer, and Shobhit Shukla, the Company’s President, on administrative leave from their respective positions with the Company pending an internal investigation conducted by outside legal counsel on behalf of the Committee.
Appointed
(interim)
Gladys Kong
interim Chief Executive Officer
Near Intelligence, Inc.
On October 1, 2023, the Board appointed Gladys Kong, the Company’s Chief Operating Officer and Secretary, to serve as the Company’s interim Chief Executive Officer.
Appointed
Brent Lucas
Chief Executive Officer
COCH ·
Envoy Medical, Inc.
Brent Lucas was appointed to serve as the Chief Executive Officer
Appointed
David R. Wells
Chief Financial Officer
COCH ·
Envoy Medical, Inc.
David R. Wells was appointed to serve as the Chief Financial Officer
Appointed
Gregory A. Sigrist
Executive Vice President, Chief Financial Officer
CASH ·
PATHWARD FINANCIAL, INC.
On October 2, 2023, Pathward Financial, Inc. (the “Company”) appointed Gregory A. Sigrist as Executive Vice President, Chief Financial Officer of the Company and Pathward, N.A., (the “Bank”) effective immediately after the filing of the Form 10-K for the fiscal year ended September 30, 2023
Appointed
(interim)
Matthew Brown
Interim Chief Financial Officer
Exela Technologies, Inc.
Matthew Brown, the President of the Company’s subsidiary, ETI-MNA, LLC (“ETI-MNA”), was appointed as the Company’s Interim Chief Financial Officer.
Departed
Shrikant Sortur
Chief Financial Officer
Exela Technologies, Inc.
Shrikant Sortur notified Exela Technologies, Inc. (the “Company” or “Exela”) of his resignation as Chief Financial Officer of the Company effective October 2, 2023.
Departed
Amit Joshi
Chief Financial Officer
Apollo Debt Solutions BDC
On June 2, 2023, Amit Joshi notified Apollo Debt Solutions BDC (the “Company”) of his intention to resign as Chief Financial Officer.
Appointed
Eric Rosenberg
Chief Financial Officer
Apollo Debt Solutions BDC
On October 2, 2023, the Board of Trustees of the Company appointed Eric Rosenberg as the Company’s Chief Financial Officer, effective October 2, 2023.
Appointed
Ryan Bright
Chief Financial Officer
Slam Corp.
Also on October 4, 2023, the Company appointed Ryan Bright as the new Chief Financial Officer of the Company.
Departed
Joseph Taeid
Chief Financial Officer
Slam Corp.
On September 30, 2023, Joseph Taeid notified Slam Corp. (the “ Company ”) of his decision to resign as Chief Financial Officer of the Company, effective as of September 30, 2023.
Departed
Mark Greenblatt
Executive Vice President and Chief Financial Officer
MAYS ·
MAYS J W INC
On October 3, 2023, Mr. Mark Greenblatt tendered his resignation as Executive Vice President and Chief Financial Officer of the Company, effective December 31, 2023.
Appointed
Steven L. Lindsey
President and Chief Executive Officer
SR ·
SPIRE INC
On September 21, 2023, Spire Inc. (the “Company”) announced the appointment of Steven L. Lindsey as President and Chief Executive Officer effective October 1, 2023.
Appointed
David Tapolczay
Chief Executive Officer
CDT ·
CDT Equity Inc.
Effective upon the completion of the Business Combination, Mr. Tapolczay was appointed Chief Executive Officer.
Role change
Sandip Kapadia
Chief Financial Officer and Chief Administrative Officer
HRMY ·
Harmony Biosciences Holdings, Inc.
The Board of Directors of Harmony Biosciences Holdings, Inc. (the “Company”) appointed Sandip Kapadia, the Company’s Chief Financial Officer, to the title of Chief Financial Officer and Chief Administrative Officer, effective upon Mr. Kapadia’s acceptance on September 30, 2023.
Role change
Brian L. Grass
Chief Financial Officer
HELE ·
HELEN OF TROY LTD
On October 4, 2023, the Company announced the appointment by the Company’s Board of Directors of Brian L. Grass, age 53 , to serve as Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer of the Company, effective as of September 23, 2023.
Role change
Loriann Shelton
CFO/COO
VOXX International Corp
Ms. Shelton will assume the role of CFO/COO
Departed
Allison Davies
Chief Financial Officer and Treasurer
GIPR ·
GENERATION INCOME PROPERTIES, INC.
On September 28, 2023, Allison Davies, Chief Financial Officer and Treasurer of Generation Income Properties, Inc. (the “ Company ”), delivered a letter of resignation to the Company, pursuant to which Ms. Davies indicated her intent to resign as Chief Financial Officer and Treasurer, effective November 15, 2023 upon the filing of the Company’s Quarterly Report on Form 10-Q for the three months ended September 30, 2023.
Appointed
Corleen Roche
Chief Financial Officer
IMNM ·
Immunome Inc.
Corleen Roche 57 Chief Financial Officer
Appointed
Clay Siegall, Ph.D.
Chief Executive Officer, President, Chairman of the Board and Class I Director
IMNM ·
Immunome Inc.
Clay Siegall, Ph.D. 63 Chief Executive Officer, President, Chairman of the Board and Class I Director
Appointed
Khash-Erdene Gantumur
Chief Financial Officer
Atlantic Coastal Acquisition Corp.
Khash—Erdene Gantumur, Chief Financial Officer
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.